SC
ZBH icon

Searle & Co’s Zimmer Biomet ZBH Stock Holding History

Searle & Co’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,000
Closed -$217K – 192
2024
Q2 		$217K Hold
2,000
– – 0.05% 169
2024
Q1 		$264K Hold
2,000
– – 0.07% 141
2023
Q4 		$243K Buy
+2,000
New +$223K 0.07% 147
2015
Q3 		– Sell
-1,030
Closed -$109K – 263
2015
Q2 		$109K Hold
1,030
– – 0.09% 125
2015
Q1 		$117K Hold
1,030
– – 0.1% 124
2014
Q4 		$113K Buy
+1,030
New +$109K 0.1% 144

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Searle & Co's ZBH Position: Q3 2024 in Review

Searle & Co sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 2,000 shares — an estimated $217K sold.

Searle & Co first reported a position in ZBH in Q4 2014 and held it in 6 quarters. The position peaked at $264K in Q1 2024. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

  • Searle & Co reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
  • Searle & Co sold 2,000 Zimmer Biomet shares in Q3 2024, an estimated $217K.
  • Searle & Co first reported a position in Zimmer Biomet in Q4 2014 and held it in 6 quarters.
  • Searle & Co's Zimmer Biomet position peaked at $264K in Q1 2024.
  • 981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Searle & Co's 13F filing for Q3 2024, filed 22 Oct 2024.